| Line Item | 2026-02-28 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.3M | — | -66.1% |
| R&D Expense | $84.1M | — | +20.8% |
| SG&A Expense | $14.6M | — | +25.4% |
| Operating Income | -$92.5M | — | -47.1% |
| Income Tax | $0 | — | — |
| Net Income | -$87.2M | — | -54.7% |
| EPS (Basic) | -$0.79 | — | -17.9% |
| EPS (Diluted) | -$0.79 | — | -17.9% |
| Line Item | 2026-02-28 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $71.2M | -71.2% | -6.2% |
| Current Assets | $554.4M | -8.6% | -1.7% |
| Total Assets | $636.1M | -7.6% | +3.4% |
| Current Liabilities | $92.2M | +6.6% | +2.5% |
| Total Liabilities | $155.2M | +3.9% | +15.7% |
| Stockholders' Equity | $480.9M |
| Line Item | 2026-02-28 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$71.9M | — | -17.7% |
| Capital Expenditures | $1.0M | — | -70.0% |
| Investing Cash Flow | -$123.8M | — | -585.0% |
| Financing Cash Flow | $20.0M | — | +1256.1% |
| Free Cash Flow | -$73.0M | — | -13.0% |
| -0.0% |